China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine (CARE-TCM)

Dongzhimen Hospital, Beijing

Status: Enrolling

Conditions: Amyotrophic Lateral Sclerosis

Study type: Observational

Funder types: Other

Identifiers

NCT04885374

ALS-2021-CARE-TCM

Details and patient eligibility

About

A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).

Full description

The CARE-TCM is a prospective, multi-center, patient registry study. Eligible ALS patients with TCM treatments will be enrolled in the registry. After enrollment, this research collects the individual characteristics of patients' status. Longitudinal follow-up data are collected from both patients (primary caregivers) and their treating neurologists every 3 months for 5 years. The aims of the CARE-TCM are to: 1) explore the general characteristics of ALS patients with TCM and; 2) assess the effectiveness and safety of various TCMs on ALS based on nationwide registry outcome collecting process.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 18 years and older.
• Patients with possible, laboratory supported probable, probable, or definite ALS according to the revised El Escorial criteria.
• ALS patients treated with traditional Chinese medicine.

Exclusion criteria

• Patients who refuse informed consent.

Trial design

2,000 participants in 1 patient group

Amyotrophic lateral sclerosis patients

Description:

Amyotrophic lateral sclerosis patients with traditional Chinese medicine